CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award Chief Medical Officer acquired 46,250 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 4 Grant or award SVP, Finance & Accounting acquired 42,500 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 46,250 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 46,250 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 4 Planned sale Chief Operating Officer sold 526 shares at $16.03 ($8,434)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 10 of 41 · 809 filings